Drug-Induced Hepatitis in an Adolescent During Concomitant Use of Azithromycin and Lisdexamfetamine Dimesylate

Author:

Mabry William A.12,Lazar Linda F.3,Bobo Kelly S.12,Shelton Chasity M.12

Affiliation:

1. Department of Pharmacy (WAM, KSB, CMS), Le Bonheur Children’s Hospital, Memphis, TN

2. Department of Clinical Pharmacy and Translational Science (WAM, KSB, CMS), The University of Tennessee Health Science Center, Memphis, TN

3. Department of Pediatrics, Gastroenterology (LFL), The University of Tennessee Health Science Center, Memphis, TN

Abstract

This case report describes a 14-year-old male with signs and symptoms of drug-induced hepatotoxicity after receiving azithromycin and lisdexamfetamine dimesylate. The patient was admitted to the hospital and a liver biopsy revealed findings suggestive of drug-induced hepatitis. In this patient, it is unclear whether 1 agent individually or a combination of azithromycin and lisdexamfetamine was the cause of hepatitis. Although hepatotoxicity has been reported with azithromycin and other macrolide antibiotics in adults, such a condition has yet to be reported in pediatrics. In light of this report, providers should be aware of a potentially rare reaction of acute hepatitis when combining azithromycin and lisdexamfetamine in pediatric patients.

Publisher

Pediatric Pharmacy Advocacy Group

Subject

Pharmacology (medical),Pediatrics, Perinatology and Child Health

Reference16 articles.

1. Summary health statistics for U.S. children: National Health Interview Survey, 2012;Bloom;Vital Health Stat,2013

2. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hy­peractivity ­disorder in children and adolescents;Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management;Pediatrics,2011

3. Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study;Biederman;Clin Ther,2007

4. Eosinophilic hepatitis in an adolescent during lisdexamfetamine dimesylate treatment for ADHD;Hood;Pediatrics,2010

5. Comparative tolerability of erythromycin and new macrolide antibacterials in paediatric patients;Principi;Drug Saf,1999

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Azithromycin/lisdexamfetamine;Reactions Weekly;2023-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3